BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26899266)

  • 1. PLK-1: Angel or devil for cell cycle progression.
    Kumar S; Sharma AR; Sharma G; Chakraborty C; Kim J
    Biochim Biophys Acta; 2016 Apr; 1865(2):190-203. PubMed ID: 26899266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitotic kinases: the key to duplication, segregation, and cytokinesis errors, chromosomal instability, and oncogenesis.
    Li JJ; Li SA
    Pharmacol Ther; 2006 Sep; 111(3):974-84. PubMed ID: 16603252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology.
    Schöffski P
    Oncologist; 2009 Jun; 14(6):559-70. PubMed ID: 19474163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory functional territory of PLK-1 and their substrates beyond mitosis.
    Kumar S; Sharma G; Chakraborty C; Sharma AR; Kim J
    Oncotarget; 2017 Jun; 8(23):37942-37962. PubMed ID: 28415805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis.
    Kumar S; Kim J
    Biomed Res Int; 2015; 2015():705745. PubMed ID: 26557691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polo box domain of Plk3 functions as a centrosome localization signal, overexpression of which causes mitotic arrest, cytokinesis defects, and apoptosis.
    Jiang N; Wang X; Jhanwar-Uniyal M; Darzynkiewicz Z; Dai W
    J Biol Chem; 2006 Apr; 281(15):10577-82. PubMed ID: 16478733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The serine/threonine kinases that control cell cycle progression as therapeutic targets].
    Diallo A; Prigent C
    Bull Cancer; 2011 Nov; 98(11):1335-45. PubMed ID: 22020767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polo-like kinases and Chk2 at the interface of DNA damage checkpoint pathways and mitotic regulation.
    Tsvetkov L
    IUBMB Life; 2004 Aug; 56(8):449-56. PubMed ID: 15545224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical genetics reveals the requirement for Polo-like kinase 1 activity in positioning RhoA and triggering cytokinesis in human cells.
    Burkard ME; Randall CL; Larochelle S; Zhang C; Shokat KM; Fisher RP; Jallepalli PV
    Proc Natl Acad Sci U S A; 2007 Mar; 104(11):4383-8. PubMed ID: 17360533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The polo-like kinase PLKA is required for initiation and progression through mitosis in the filamentous fungus Aspergillus nidulans.
    Bachewich C; Masker K; Osmani S
    Mol Microbiol; 2005 Jan; 55(2):572-87. PubMed ID: 15659171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional studies on the role of the C-terminal domain of mammalian polo-like kinase.
    Jang YJ; Lin CY; Ma S; Erikson RL
    Proc Natl Acad Sci U S A; 2002 Feb; 99(4):1984-9. PubMed ID: 11854496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polo-like kinase-1 is a target of the DNA damage checkpoint.
    Smits VA; Klompmaker R; Arnaud L; Rijksen G; Nigg EA; Medema RH
    Nat Cell Biol; 2000 Sep; 2(9):672-6. PubMed ID: 10980711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1.
    Ree AH; Bratland A; Nome RV; Stokke T; Fodstad Ø
    Oncogene; 2003 Dec; 22(55):8952-5. PubMed ID: 14654792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Megakaryocyte polyploidization is associated with decreased expression of polo-like kinase (PLK).
    Yagi M; Roth GJ
    J Thromb Haemost; 2006 Sep; 4(9):2028-34. PubMed ID: 16805859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of threonine 210 and the role of serine 137 in the regulation of mammalian polo-like kinase.
    Jang YJ; Ma S; Terada Y; Erikson RL
    J Biol Chem; 2002 Nov; 277(46):44115-20. PubMed ID: 12207013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the Plk gene lead to instability of Plk protein in human tumour cell lines.
    Simizu S; Osada H
    Nat Cell Biol; 2000 Nov; 2(11):852-4. PubMed ID: 11056542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ionizing radiation inhibits the PLK cell cycle gene in a G2 checkpoint-dependent manner.
    Ree AH; Bratland A; Solberg Landsverk K; Fodstad O
    Anticancer Res; 2004; 24(2B):555-62. PubMed ID: 15160994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Messenger RNA levels of the Polo-like kinase gene (PLK) correlate with cytokinesis in the Trypanosoma rangeli cell cycle.
    Prestes EB; Stoco PH; de Moraes MH; Moura H; Grisard EC
    Exp Parasitol; 2019 Sep; 204():107727. PubMed ID: 31344389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitination and proteasome mediated degradation of polo-like kinase.
    Ferris DK; Maloid SC; Li CC
    Biochem Biophys Res Commun; 1998 Nov; 252(2):340-4. PubMed ID: 9826531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P21-activated kinase is required for mitotic progression and regulates Plk1.
    Maroto B; Ye MB; von Lohneysen K; Schnelzer A; Knaus UG
    Oncogene; 2008 Aug; 27(36):4900-8. PubMed ID: 18427546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.